Abstract
The predominant field strains of Marek’s disease virus in Guangxi were clearly different from the vaccine strain CVI988/Rispens based on sequencing of the envelope glycoprotein I (gI), glycoprotein E (gE) and oncogenic meq genes. These differences may be partly responsible for the most recent outbreaks in Guangxi.
Similar content being viewed by others
References
Arvin AM, Sharp M, Smith S, Koropchak CM, Diaz PS, Kinchington P, Ruyechan W, Hay J (1991) Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4 + or CD8 + phenotype. J Immunol 146:257–264
Cui ZhZh, Wei P, Ding JB, Zhu SJ (2004) Molecular Comparative of Marek’s disease virus strains of different pathotypes for there gI, gE, pp38 and meq gene. J Shandong Agric Univ (Natural Science Edition) 35:1–5
Huang AG, Jiang YW, Bai AB, Pan BJ, Chen XN, Yao RY, Zheng RB, Feng J (1998) Evaluation of the pathogenicity of Marek’s disease virus. Chin J Vet Med 11:5–6
Markowski-Grimsrud CJ, Schat KA (2002) Cytotoxic T lymphocyte responses to Marek’s disease herpesvirus-encoded glycoproteins. Vet Immunol Immunopathol 90:133–144
Niikura M, Dodgson J, Cheng H (2006) Direct evidence of host genome acquisition by the alphaherpesvirus Marek’s disease virus. Arch Virol 151:537–549
Renz KG, Cheetham BF, Walkden-Brown SW (2008) Amino acid substitutions or insertion in the Meq proteins could affect their transactivation and transformation abilities. In: 8th International Marek’s Disease Symposium. James Cook University, Townsville, Queensland, Australia
Santin ER, Shamblin CE, Prigge JT, Arumugaswami V, Dienglewicz RL, Parcells MS (2006) Examination of the effect of a naturally occurring mutation in glycoprotein L on Marek’s disease virus pathogenesis. Avian Dis 50:96–103
Schumacher D, Tischer BK, Reddy SM, Osterrieder N (2001) Glycoproteins E and I of Marek’s disease virus serotype 1 are essential for virus growth in cultured cells. J Virol 75:11307–11318
Schumacher D, Tischer BK, Teifke JP, Wink K, Osterrieder N (2002) Generation of a permanent cell line that supports efficient growth of Marek’s disease virus (MDV) by constitutive expression of MDV glycoprotein E. J Gen Virol 83:1987–1992
Shamblin CE, Greene N, Arumugaswami V, Dienglewicz RL, Parcells MS (2004) Comparative analysis of Marek’s disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence. Vet Microbiol 102:147–167
Spatz SJ, Silva RF (2007) Sequence determination of variable regions within the genomes of gallid herpesvirus-2 pathotype. Arch Virol 152:1665–7168
Tavlarides-Hontz P, Kumar PM, Amortegui JR, Osterrieder N, Parcells MS (2009) A deletion within glycoprotein L of Marek’s disease virus (MDV) field isolates correlates with a decrease in bivalent MDV vaccine efficacy in contact-exposed chickens. Avian Dis 53:287–296
Teng LQ, Wei P, Song ZhB, Yang DL (2009) Evaluation of the pathogenicity of a field isolate of Marek’s disease virus integrated with retroviral long terminal repeat sequence. Chin J Virol 25:376–381
Wei P, Cui ZhZh (2004) The comparison of meq genes amplified from different pathotypes of Marek’s disease virus. Abstract book of the 7th International MD Symposium. St. Catherine’s college, Oxford
Wei P, Cui ZhZh, Long JX, Jin WJ, Liu YL (2002) The development of a monoclonal antibody (McAb) against MEQ protein of Marek’s disease virus (MDV) and its applications. J Guangxi Univ 27:5–9
Witter RL (1997) Increased virulence of Marek’s disease virus field isolates. Avian Dis 41:149–163
Wu P, Reed WM, Lee LF (2001) Glycoproteins H and L of Marek’s disease virus form a hetero-oligomer essential for translocation and cell surface expression. Arch Virol 146:983–992
Zuo TR, Zhao ZY, Wei P, Wei XX, Li Y, Mo ML (2007) Isolation and identification of a field isolate of Marek’s Disease Virus with acute oncogenicity. Chin J Virol 23:218–223
Acknowledgments
This research was supported by grants from the Nature Science Foundation of China (NFNC no. 30860206, 39860055 and 30460099 and the Research Key Program of Guangxi University (no. 2005ZD01).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Teng, Lq., Wei, P., Song, Zb. et al. Molecular epidemiological investigation of Marek’s disease virus from Guangxi, China. Arch Virol 156, 203–206 (2011). https://doi.org/10.1007/s00705-010-0840-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-010-0840-8